News

The Dow Jones Industrial Average gave up an almost 300-point gain to end lower, while the S&P 500 closed flat, on Wednesday after the Federal Reserve left interest rates unchanged but raised its ...
Nuvation Bio's FDA approval for IBTROZI isn't boosting its stock. Learn about NUVB's financial risks, valuation concerns, and ...
Analysts have to remember that the Federal Reserve is operating under a different set of parameters than in previous times.
A Steady Hand for Choppy Waters Dividend stocks are a cornerstone for savvy investors seeking stability and income, especially amid the Middle East turmoil and uncertainty clouding Federal Reserve ...
U.S. stocks drifted to a mixed finish after the Federal Reserve indicated it may cut interest rates twice this year, though ...
The Senate on Wednesday passed the GENIUS Act, a breakthrough for the cryptocurrency industry that could have a far-reaching ...
President Trump’s trade war is likely to lead to higher prices and slower growth, a challenging combination for the Fed. War in the Middle East could make the job harder still.